BlueDot
17 Apr, 2020BlueDot’s outbreak risk software safeguards lives by mitigating exposure to infectious diseases that threaten human health, security, and prosperity.
- BlueDot was among the first in the world to identify the emerging risk from COVID-19 in Hubei province and notify our clients via our Insights platform, validating our capabilities as a global early warning system for infectious disease.
- BlueDot published the first scientific paper on COVID-19, accurately predicting its global spread using our proprietary models.
- BlueDot disseminated bespoke, near-real-time insights to clients including governments, hospitals and airlines, revealing COVID-19’s movements. Our intelligence is based on over 40 pathogen-specific datasets reflecting disease mobility and outbreak potential.
- BlueDot delivers regular reporting to answer the most pressing questions, including which countries reported local cases, how severely cities outside of China were affected, and which cities risked transmitting COVID-19 despite having no official cases.
How it works
BlueDot quantifies the risk of exposure to infectious diseases globally, enabling you to protect human health.
We detect outbreaks of over 150 different pathogens, toxins, and syndromes in near-real time. Our platform scan over 100,000 official and mass media sources in 65 languages per day.
We anticipate dispersion of disease, locally and globally, using anonymous, aggregated data on billions of flight itineraries and hundreds of millions of mobile devices.
We anticipate impact of disease spread globally and globally using diverse datasets:
- Billions of flight itineraries
- Real time climate conditions
- Health system capacity
- Animal & insect populations
We empower you to mobilize timely, effective, efficient, coordinated, and measured responses to epidemic threats